NCT01376011

Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement

Hypoxia-inducible Transcription Factor 1 (HIF-1) in Vascular Aging

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 106 (actual)
• Sponsor: Brigham and Women's Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to find out if quercetin can increase blood levels of hypoxia-inducible transcription factor 1 (HIF-1 protein) and to see if there is a corresponding increase in blood flow to the brain.

Conditions

• Stroke
• Problem of Aging

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	quercetin/placebo	Quercetin 500mg once per day versus placebo

Timeline

• Start date: 2009-06-01
• Primary completion: 2012-06-01
• Completion: 2014-12-01
• First posted: 2011-06-20
• Last updated: 2015-01-28

Locations

1 site across 1 country: United States